Sophia Humphreys, PharmD, MHA, BCBBS, discusses highlights of the Institute for Value-Based Medicine® (IVBM) event, held in partnership with Providence Health System, that recently took place in Newport Beach, California.
Sophia Humphreys, PharmD, MHA, BCBBS, director of system pharmacy formulary management and clinical programs at Sutter Health and clinical assistant professor, University of Washington School of Pharmacy, spoke with The American Journal of Managed Care® about the Newport Beach Institute for Value-Based Medicine (IVBM) event, of which she was a cochair.
At the event, experts spoke on the intersection of medicine and pharmacy, and her presentation was titled "Formulary Management Is a Team Sport."
Transcript
What were you most looking forward to at the IVBM held in Newport Beach?
That's a great question, actually. This particular conference, we are going to host in collaboration with Providence Health System. That's a very large IDN [integrated delivery network] on the West Coast. I will be cohosting with Elie Bahou, [PharmD, MBA,] who is the chief pharmacy officer of Providence Health System. We are going to bring in experts from both Providence and Sutter Health, as well as Baptist Health, which is a sister organization from Florida. We're going to have experts from both pharmacy background, as well as medical background. I'm really looking forward to listening to a lot of our expert discussions regarding medication management, regarding House plan navigations, also regarding academic detailing from Harry Peled, [MD, FACC,] who is the system formulary management co-chair from Providence Health.
Was there anything you were particularly excited to talk about in your presentation?
So, as I have mentioned probably in my previous discussions, I have been managing formulary for health systems large and small [for] the past 20 years. I always said I have [had] 4 bosses in my entire career and all of them gave me 1 duty, which is to provide the best patient care with the most financially sustainable methodologies. Which means we want to have high-quality care at lower costs.
Within this particular discussion, I would like to cover a little bit about our current medication market outlook and then dive deep into what are the basic principles for formulary management and also who [is] involved, both the internal customers and external customers. Also, how we collaborate within health systems and also collaborate with external customers, such as government and regulatory bodies and professional organizations, as well as even drug manufacturers, so that we all serve 1 purpose, which is to take care of our patients and improve their overall quality of life and clinical outcomes.
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Read More